CATO argues that the proposed defense supplemental budget represents wasteful and unnecessary spending, largely driven by reactive measures related to the war in Iran. The article highlights that significant portions of this funding are dedicated to operational expenses and resupplying depleted munitions inventories. Furthermore, it notes that actual military outlays are consistently underreported because multiple agencies contribute funds outside the Department of Defense. Consequently, the continuous expansion of defense spending is deemed fiscally irresponsible, adding billions to an already excessive budget without providing clear benefits to American taxpayers.
Correcting Some of the Mistakes Cops Make When Practicing Medicine
English Summary
H.R. 9186 proposes reforming the Controlled Substances Act by updating definitions of "accepted medical use," distinguishing dependence from abuse, and prioritizing scientific evidence in drug scheduling. The bill addresses how current overly restrictive definitions and law enforcement influence have impeded medical research and patient access to potentially therapeutic substances like psychedelics. Key reforms include broadening what qualifies as accepted medical use beyond FDA approval alone and requiring regulators to balance risks against medical benefits rather than focusing primarily on harms. If enacted, the bill could reduce research barriers, improve clinical care for patients, and move drug policy toward a more evidence-based approach, though it does not fully resolve law enforcement's role in medical decisions.
中文摘要
H.R. 9186提案建議改革《管制物質法》，通過更新「認可醫療用途」的定義、區分依賴與濫用，以及在藥物分類中優先採用科學證據。該法案指出，現行過度限制性的定義和執法影響如何妨礙醫學研究和患者獲取具潛在治療價值的物質（例如迷幻藥）。主要改革包括：拓寬「認可醫療用途」的範圍，超越美國食品藥物管理局(FDA)的批准；以及要求監管機構在衡量風險與醫療效益時取得平衡，而非僅關注潛在危害。若該法案頒布實施，將可能降低研究障礙、改善患者臨床護理，並推動藥物政策朝向更為證據驅動的方向發展，儘管仍未完全解決執法部門在醫療決策中的角色問題。
Related Entries
-
1.
-
2.
The Cato Institute argues that federal welfare programs are plagued by systemic design flaws leading to massive waste, fraud, and abuse of taxpayer funds. These losses stem primarily from a 'financing mismatch,' where states administer benefits but the federal government bears most of the cost, weakening local incentives for proper enforcement. Compounding this is administrative complexity and outdated verification systems, which facilitate improper payments and rule manipulation across programs like Medicaid and SNAP. To curb these multi-trillion dollar losses, the authors recommend structural reforms—such as converting programs into zero-growth block grants or strengthening eligibility rules—to align state financial incentives with federal accountability.
-
3.
Recent court rulings demonstrate significant judicial resistance to federal efforts attempting to intervene in state-level election administration. Judges have blocked presidential attempts to mandate changes to mail-in balloting, prevented the creation of large voter databases using inaccurate data, and generally dismissed suits demanding state voter files. These findings indicate that core electoral processes remain largely protected by state autonomy against broad federal mandates. Consequently, policy strategists should anticipate continued legal challenges limiting the scope of executive power in election mechanics, reinforcing decentralized control over voting procedures.
-
4."Overwhelmingly a Positive Development": FDA Finally Stops Blocking Safe, Effective Bemotrizinol Sunscreens (CATO)
The publication argues that the FDA's regulatory process is overly restrictive and detrimental to public health, using sunscreen ingredients like bemotrizinol as a primary example of unnecessary overregulation. The core finding is that the agency frequently commits 'Type II errors'—blocking beneficial products—which harms consumers more than it helps, due to political incentives focused only on avoiding Type I errors (blocking harmful substances). For policy reform, the author recommends Congress eliminate or drastically curtail FDA power and immediately remove barriers allowing US consumers access to health products already approved in other developed nations. This shift is presented as essential for promoting individual liberty and consumer choice over government control.
-
5.
CATO argues that current judicial interpretations of FOIA's Exemption 7 are flawed because some circuits apply a "per se" rule, automatically exempting any document compiled by law enforcement agencies regardless of its actual purpose. This interpretation contradicts the plain text of FOIA, which requires proof that records were compiled for legitimate law enforcement objectives. The pending Supreme Court case underscores this conflict, as broad exemptions allow the government to shield potential abuses and surveillance overreach from public scrutiny. Policy-wise, overturning the "per se" rule is critical to restoring transparency in federal governance and ensuring that public access remains an effective tool against governmental misconduct.